<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10356780</article-id>
    <article-id pub-id-type="pmid">37399102</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btad421</article-id>
    <article-id pub-id-type="publisher-id">btad421</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Paper</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>RNAenrich: a web server for non-coding RNA enrichment</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1263-6693</contrib-id>
        <name>
          <surname>Zhang</surname>
          <given-names>Song</given-names>
        </name>
        <aff><institution>Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People's Hospital, Hangzhou Medical College</institution>, Hangzhou, Zhejiang 310014, <country country="CN">China</country></aff>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
        <xref rid="btad421-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Amahong</surname>
          <given-names>Kuerbannisha</given-names>
        </name>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
        <xref rid="btad421-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yintao</given-names>
        </name>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
        <xref rid="btad421-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hu</surname>
          <given-names>Xiaoping</given-names>
        </name>
        <aff><institution>Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People's Hospital, Hangzhou Medical College</institution>, Hangzhou, Zhejiang 310014, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Shijie</given-names>
        </name>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lu</surname>
          <given-names>Mingkun</given-names>
        </name>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zeng</surname>
          <given-names>Zhenyu</given-names>
        </name>
        <aff><institution>Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare</institution>, Hangzhou, Zhejiang 330110, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Zhaorong</given-names>
        </name>
        <aff><institution>Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare</institution>, Hangzhou, Zhejiang 330110, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Bing</given-names>
        </name>
        <aff><institution>Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare</institution>, Hangzhou, Zhejiang 330110, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Qiu</surname>
          <given-names>Yunqing</given-names>
        </name>
        <aff><institution>State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang Provincial Key Laboratory for Drug Clinical Research and Evaluation, The First Affiliated Hospital, Zhejiang University</institution>, Hangzhou, Zhejiang 310000, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dai</surname>
          <given-names>Haibin</given-names>
        </name>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gao</surname>
          <given-names>Jianqing</given-names>
        </name>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
        <aff><institution>Westlake Laboratory of Life Sciences and Biomedicine</institution>, Hangzhou, Zhejiang 310030, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8069-0053</contrib-id>
        <name>
          <surname>Zhu</surname>
          <given-names>Feng</given-names>
        </name>
        <aff><institution>Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital, Affiliated People's Hospital, Hangzhou Medical College</institution>, Hangzhou, Zhejiang 310014, <country country="CN">China</country></aff>
        <aff><institution>College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University</institution>, Hangzhou, Zhejiang 310058, <country country="CN">China</country></aff>
        <xref rid="btad421-cor1" ref-type="corresp"/>
        <!--prof.zhufeng@gmail.com-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Robinson</surname>
          <given-names>Peter</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btad421-cor1">Corresponding author. College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China. E-mail: <email>zhufeng@zju.edu.cn</email>, <email>prof.zhufeng@gmail.com</email> (F.Z.)</corresp>
      <fn id="btad421-FM1">
        <p>Song Zhang and Kuerbannisha Amahong Equal contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-07-03">
      <day>03</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>03</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <volume>39</volume>
    <issue>7</issue>
    <elocation-id>btad421</elocation-id>
    <history>
      <date date-type="received">
        <day>16</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>28</day>
        <month>4</month>
        <year>2023</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>6</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>03</day>
        <month>7</month>
        <year>2023</year>
      </date>
      <date date-type="corrected-typeset">
        <day>19</day>
        <month>7</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btad421.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>With the rapid advances of RNA sequencing and microarray technologies in non-coding RNA (ncRNA) research, functional tools that perform enrichment analysis for ncRNAs are needed. On the one hand, because of the rapidly growing interest in circRNAs, snoRNAs, and piRNAs, it is essential to develop tools for enrichment analysis for these newly emerged ncRNAs. On the other hand, due to the key role of ncRNAs’ interacting target in the determination of their function, the interactions between ncRNA and its corresponding target should be fully considered in functional enrichment. Based on the ncRNA–mRNA/protein-function strategy, some tools have been developed to functionally analyze a single type of ncRNA (the majority focuses on miRNA); in addition, some tools adopt predicted target data and lead to only low-confidence results.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>Herein, an online tool named RNAenrich was developed to enable the comprehensive and accurate enrichment analysis of ncRNAs. It is unique in (i) realizing the enrichment analysis for various RNA types in humans and mice, such as miRNA, lncRNA, circRNA, snoRNA, piRNA, and mRNA; (ii) extending the analysis by introducing millions of experimentally validated data of RNA–target interactions as a built-in database; and (iii) providing a comprehensive interacting network among various ncRNAs and targets to facilitate the mechanistic study of ncRNA function. Importantly, RNAenrich led to a more comprehensive and accurate enrichment analysis in a COVID-19-related miRNA case, which was largely attributed to its coverage of comprehensive ncRNA–target interactions.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>RNAenrich is now freely accessible at <ext-link xlink:href="https://idrblab.org/rnaenr/" ext-link-type="uri">https://idrblab.org/rnaenr/</ext-link>.</p>
      </sec>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="btad421-F5">
          <label>Graphical Abstract</label>
          <graphic xlink:href="btad421f5" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Natural Science Foundation of Zhejiang Province</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004731</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>LR21H300001</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>22220102001</award-id>
        <award-id>U1909208</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Over the past quarter-century, non-coding RNAs (ncRNAs) have guided a prevalent trend in biomedical and life science research, and interest in ncRNAs and associated fields is continually expanding (<xref rid="btad421-B48" ref-type="bibr">Lee <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B69" ref-type="bibr">Vidovic <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B68" ref-type="bibr">Venkatesh <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="btad421-B90" ref-type="bibr">Yoo <italic toggle="yes">et al.</italic> 2021a</xref>). With the increasing amount of in depth ncRNA research, several kinds of regulatory ncRNAs, including microRNA (miRNA) (<xref rid="btad421-B23" ref-type="bibr">Gebert and MacRae 2019</xref>), long non-coding RNA (lncRNA) (<xref rid="btad421-B21" ref-type="bibr">Elling <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B65" ref-type="bibr">Statello <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="btad421-B71" ref-type="bibr">Vollmers <italic toggle="yes">et al.</italic> 2021</xref>), circular RNA (circRNA) (<xref rid="btad421-B92" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="btad421-B47" ref-type="bibr">Kristensen <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="btad421-B39" ref-type="bibr">Jia <italic toggle="yes">et al.</italic> 2020</xref>), small nucleolar RNA (snoRNA) (<xref rid="btad421-B53" ref-type="bibr">Liang <italic toggle="yes">et al.</italic> 2019</xref>), and piwi-interacting RNA (piRNA) (<xref rid="btad421-B60" ref-type="bibr">Ozata <italic toggle="yes">et al.</italic> 2019</xref>), have received enormous attention from researchers due to their capacities to orchestrate gene expression (<xref rid="btad421-B10" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="btad421-B12" ref-type="bibr">2019b</xref>, <xref rid="btad421-B72" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2021a</xref>). Uncovering their molecular mechanism during cellular processes is crucial for solving physiological and pathophysiological problems (<xref rid="btad421-B2" ref-type="bibr">Beermann <italic toggle="yes">et al.</italic> 2016</xref>, <xref rid="btad421-B27" ref-type="bibr">Goodall and Wickramasinghe 2021</xref>). Currently, the theoretical system of ncRNA regulation has been well established based on the cumulation of millions of published studies (<xref rid="btad421-B92" ref-type="bibr">Zeng <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="btad421-B21" ref-type="bibr">Elling <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B23" ref-type="bibr">Gebert and MacRae 2019</xref>, <xref rid="btad421-B47" ref-type="bibr">Kristensen <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="btad421-B39" ref-type="bibr">Jia <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B65" ref-type="bibr">Statello <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="btad421-B71" ref-type="bibr">Vollmers <italic toggle="yes">et al.</italic> 2021</xref>). For example, miRNA can bind to specific mRNAs to influence their stability or translation (<xref rid="btad421-B61" ref-type="bibr">Pillman <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B23" ref-type="bibr">Gebert and MacRae 2019</xref>); lncRNA and circRNA are frequently involved in the process of sustaining mRNA and protein stability via interactions, and can also absorb miRNAs to deprive their original function (<xref rid="btad421-B47" ref-type="bibr">Kristensen <italic toggle="yes">et al.</italic> 2019</xref>, <xref rid="btad421-B65" ref-type="bibr">Statello <italic toggle="yes">et al.</italic> 2021</xref>); snoRNA modulates gene expression by controlling mRNA processing (<xref rid="btad421-B53" ref-type="bibr">Liang <italic toggle="yes">et al.</italic> 2019</xref>); and piRNA induces gene silencing in the formation of RNA–protein complexes with piwi-subfamily Argonaute proteins (<xref rid="btad421-B60" ref-type="bibr">Ozata <italic toggle="yes">et al.</italic> 2019</xref>). Therefore, a growing number of databases have been developed to accommodate the collection of ncRNA-related interactions [e.g. miRNA–mRNA (<xref rid="btad421-B89" ref-type="bibr">Yang <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B34" ref-type="bibr">Huang <italic toggle="yes">et al.</italic> 2022</xref>) and lncRNA–miRNA (<xref rid="btad421-B51" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2014</xref>, <xref rid="btad421-B18" ref-type="bibr">Cruickshank <italic toggle="yes">et al.</italic> 2021</xref>)], as well as other associations [e.g. ncRNA–disease (<xref rid="btad421-B66" ref-type="bibr">Tang <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B58" ref-type="bibr">Ning <italic toggle="yes">et al.</italic> 2021</xref>), and ncRNA-pathway (<xref rid="btad421-B42" ref-type="bibr">Kehl <italic toggle="yes">et al.</italic> 2020</xref>)].</p>
    <p>Enrichment analysis is frequently applied to describe the function (involved-disease, pathway, cell process, etc.) of a gene set during the process of disease development and reveal the molecular mechanism of diverse diseases (<xref rid="btad421-B20" ref-type="bibr">Delorey <italic toggle="yes">et al.</italic> 2021</xref>). With the development of ncRNA-related association databases, some computational tools that focus on the enrichment of ncRNAs have been well constructed (<xref rid="btad421-B83" ref-type="bibr">Wu and Watson 2009</xref>, <xref rid="btad421-B29" ref-type="bibr">Hsu <italic toggle="yes">et al.</italic> 2011</xref>, <xref rid="btad421-B70" ref-type="bibr">Vlachos <italic toggle="yes">et al.</italic> 2015</xref>, <xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B8" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021a</xref>, <xref rid="btad421-B59" ref-type="bibr">Olgun <italic toggle="yes">et al.</italic> 2021</xref>), among them, TAM (<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>) and miEAA (<xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>) carry out an enrichment analysis for miRNA, and LncSEA (<xref rid="btad421-B8" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021a</xref>) is for lncRNA. Currently, the available enrichment strategies for ncRNA include (i) mapping a ncRNA with a function (disease or pathway) according to the literature or database (<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>) and (ii) matching a ncRNA with a target mRNA/protein according to the literature or prediction data and then matching the protein with a term according to a well-established knowledge hierarchy (<xref rid="btad421-B43" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2021</xref>). As reported, the former fails to cover the effect of diverse ncRNA interactions; therefore, this strategy may catch less valuable information (<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>). Meanwhile, the predicted data of the latter may reduce the accuracy of the enrichment results (<xref rid="btad421-B36" ref-type="bibr">Huntley <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B43" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2021</xref>). In other words, due to the increasing interest in circRNAs, snoRNAs and piRNAs, it is essential to enable enrichment analysis of these newly identified ncRNAs. Moreover, since the function of ncRNAs depends heavily on their interacting target, the interactions between ncRNA and the corresponding target should be fully considered in functional enrichment (<xref rid="btad421-B43" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2021</xref>). However, little tool that enables these valuable functions has yet been available for diverse ncRNAs.</p>
    <p>In this study, a novel online tool named RNAenrich was developed to enable comprehensive functional enrichment analysis of diverse human and mouse ncRNAs. First, the interaction data between ncRNAs (circRNA, lncRNA, miRNA, piRNA, snoRNA, etc.) and their corresponding targets were collected using a systematic literature review in PubMed and various existing databases, which resulted in ∼1.87 million experimentally validated interactions. Second, enrichment analysis was realized by supporting a variety of functional categories, such as signaling pathway, metabolic pathway, Gene Ontology, disease, and therapeutic target. To the best of our knowledge, this tool is unique in that (i) it provides enrichment analysis for the most diverse types of ncRNA (not only lncRNA &amp; miRNA, but also circRNA, piRNA &amp; snoRNA) compared with existing tools; (ii) it extends the analysis by introducing millions of experiment-validated ncRNA–target interactions as a built-in database; and (iii) it provides an interacting network among various RNAs and different targets to facilitate the mechanistic study of ncRNA function. RNAenrich is now freely accessible without any login requirement at <ext-link xlink:href="https://idrblab.org/rnaenr/" ext-link-type="uri">https://idrblab.org/rnaenr/</ext-link>.</p>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <sec>
      <title>2.1 The functional enrichment strategy adopted in RNAenrich</title>
      <p>Currently, the following two types of enrichment strategies for ncRNA sets are commonly used: putting an ncRNA into a disease, pathway, function, tissue location, etc., or matching an ncRNA with target functional mRNA/protein and then mapping the mRNA with various given terms. To ensure the diversity and reliability of the analysis, in this study, the second strategy was adopted. Therefore, the strategy of this study is matching an ncRNA with a target mRNA/protein according to experimentally validated data and then matching the protein with function according to well-established knowledge hierarchy, in which experimentally validated data ensure the accuracy of the enrichment results. Besides, the experimentally validated ncRNA interaction data were included high-confidence (low-throughput experimental data) and low-confidence (high-throughput experimental data) interactions. Users can choose confidence level according to their preferences. The tool has been developed so that an RNA list by RNA sequencing can be enriched to analyze associated functions, such as pathways and diseases.</p>
      <p>RNAenrich can enrich five types of ncRNAs to analyze their function, including miRNAs, lncRNAs, circRNAs, snoRNAs, and piRNAs. All these ncRNAs generally interact with specific mRNAs or proteins and control their expression or activity, ultimately affecting the protein-induced signaling pathway. The following summary was well concluded from millions of studies: (i) miRNA generally interacts with specific mRNA and affects its stability and translation; (ii) lncRNA and circRNA can interact with miRNA to deprive its original functions and can also interact with mRNA and protein to affect their expression or activity; (iii) snoRNA regulates gene expression by controlling mRNA processing; and (iv) piRNA induces gene silencing by forming RNA–protein complexes with piwi-subfamily Argonaute proteins. In short, the functions of these five types of ncRNA heavily rely on interacting mRNAs or proteins. Therefore, the first step for RNAenrich analysis was matching the target mRNA/protein of the query ncRNA; all ncRNA–mRNA/protein interaction data were from diverse databases. After obtaining the targets of query ncRNA, the second step was carrying out an enrichment analysis via traditional enrichment databases, such as KEGG and Gene Ontology.</p>
    </sec>
    <sec>
      <title>2.2 The ncRNA–target interaction data in RNAenrich</title>
      <p>A variety of databases were included to determine the experimentally validated interactions, such as the miRNA–mRNA interactions from miRTarBase (<xref rid="btad421-B34" ref-type="bibr">Huang <italic toggle="yes">et al.</italic> 2022</xref>), miRecords (<xref rid="btad421-B86" ref-type="bibr">Xiao <italic toggle="yes">et al.</italic> 2009</xref>), miRSponge (<xref rid="btad421-B77" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2015</xref>), OncomiRDB (<xref rid="btad421-B74" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2014</xref>), Gene Ontology (<xref rid="btad421-B37" ref-type="bibr">Huntley <italic toggle="yes">et al.</italic> 2016</xref>, <xref rid="btad421-B24" ref-type="bibr">Gene Ontology Consortium 2021</xref>), IntAct (<xref rid="btad421-B19" ref-type="bibr">Del Toro <italic toggle="yes">et al.</italic> 2022</xref>), StarBase (<xref rid="btad421-B51" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2014</xref>), and TarBase (<xref rid="btad421-B41" ref-type="bibr">Karagkouni <italic toggle="yes">et al.</italic> 2018</xref>); lncRNA–mRNA, lncRNA–protein, and lncRNA–miRNA interactions in LncTarD (<xref rid="btad421-B97" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic> 2020</xref>), LncACTdb (<xref rid="btad421-B76" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2022b</xref>), LncRNA2Target (<xref rid="btad421-B16" ref-type="bibr">Cheng <italic toggle="yes">et al.</italic> 2019</xref>), and StarBase (<xref rid="btad421-B51" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2014</xref>); circRNA–mRNA, circRNA–protein, and circRNA–miRNA interactions circRNADisease (<xref rid="btad421-B98" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic> 2018</xref>), StarBase (<xref rid="btad421-B51" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2014</xref>); snoRNA–mRNA and snoRNA–miRNA in SnoDB (<xref rid="btad421-B4" ref-type="bibr">Bouchard-Bourelle <italic toggle="yes">et al.</italic> 2020</xref>), StarBase (<xref rid="btad421-B51" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2014</xref>); and piRNA–mRNA and piRNA–protein in piRBase (<xref rid="btad421-B75" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2022a</xref>). Among these, all interactions were recorded as strong- or weak-validation based on the selection of coefficient level. Overall, a total of 1.87 million ncRNA–target interaction data were collected and included in RNAenrich. These data are rich resources that are waiting for machine-learning tools (<xref rid="btad421-B11" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2018b</xref>, <xref rid="btad421-B52" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B56" ref-type="bibr">Meyer <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B54" ref-type="bibr">Liu <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="btad421-B73" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2021b</xref>, <xref rid="btad421-B31" ref-type="bibr">Hu <italic toggle="yes">et al.</italic> 2022a</xref>, <xref rid="btad421-B84" ref-type="bibr">Xia <italic toggle="yes">et al.</italic> 2022a</xref>, <xref rid="btad421-B85" ref-type="bibr">b</xref>, <xref rid="btad421-B49" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2023</xref>) to analyze, especially feature selection (<xref rid="btad421-B14" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2018c</xref>, <xref rid="btad421-B15" ref-type="bibr">2020</xref>, <xref rid="btad421-B13" ref-type="bibr">2021b</xref>, <xref rid="btad421-B30" ref-type="bibr">Hu <italic toggle="yes">et al.</italic> 2021</xref>, <xref rid="btad421-B32" ref-type="bibr">2022b</xref>, <xref rid="btad421-B67" ref-type="bibr">Too <italic toggle="yes">et al.</italic> 2022</xref>, <xref rid="btad421-B95" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2023</xref>) methods have great potential in this scenario.</p>
    </sec>
    <sec>
      <title>2.3 The diverse functions that can be enriched in RNAenrich</title>
      <p>Moreover, five popular databases were used in RNAenrich to facilitate the functional enrichment, including the KEGG (<xref rid="btad421-B40" ref-type="bibr">Kanehisa <italic toggle="yes">et al.</italic> 2021</xref>) and Reactome (<xref rid="btad421-B26" ref-type="bibr">Gillespie <italic toggle="yes">et al.</italic> 2022</xref>), which provided protein-directed signaling pathways that the ncRNA participate in; the SMPDB (<xref rid="btad421-B38" ref-type="bibr">Jewison <italic toggle="yes">et al.</italic> 2014</xref>), which offered metabolite-based pathways or reactions that ncRNAs regulate; Gene Ontology (<xref rid="btad421-B24" ref-type="bibr">Gene Ontology Consortium 2021</xref>), which contributed descriptions of the functional role of ncRNAs, their contribution to biological processes and location in the cell (especially, direct ncRNA biological process, cellular component, and molecular function annotations of Gene Ontology database are also included in built-in database of RNAenrich for enrichment analysis); TTD (<xref rid="btad421-B99" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic> 2022</xref>) and KEGG (<xref rid="btad421-B40" ref-type="bibr">Kanehisa <italic toggle="yes">et al.</italic> 2021</xref>), which described the RNA-mediated occurrence and development of disease indication; and TTD (<xref rid="btad421-B99" ref-type="bibr">Zhou <italic toggle="yes">et al.</italic> 2022</xref>), which illustrated the therapeutic targets that ncRNAs regulate. Such diverse functional data can significantly enhance the capacity of ncRNA enrichment.</p>
    </sec>
    <sec>
      <title>2.4 Server implementation details and required format of input</title>
      <p>RNAenrich is deployed on a web server running Cent OS Linux v7.4.1708, Apache HTTP web server v2.4.6, and Apache Tomcat servlet container. Its web interface was developed by R v3.4.1 and Shiny v0.13.1 running on Shiny-server v1.4.1.759. Various R packages were utilized in the background processes. RNAenrich can be readily accessed by all users with no login requirement, and by diverse and popular web browsers, including Google Chrome, Mozilla Firefox, Safari, and Internet Explorer. The input is the ncRNA/gene set, which can be selected from the ncRNA/gene list of RNA sequencing/microarray data or the ncRNA/gene list of prediction data. To enhance the tolerance of RNAenrich analysis, RNAenrich allows diverse ID types as input RNA format for each RNA type. Five types of ncRNA (miRNA, lncRNA, circRNA, snoRNA, and piRNA) and mRNA lists can be analyzed in RNAenrich. RNAenrich allows users to select different ID lists (<xref rid="btad421-T1" ref-type="table">Table 1</xref>). RNAcentral is an authoritative and comprehensive ncRNA database in which each ncRNA is endowed with a unique ID (<xref rid="btad421-B62" ref-type="bibr">RNAcentral Consortium 2021</xref>). Therefore, all RNAs in RNAenrich are mapped to an RNAcentral ID if it is applicable in the RNAcentral database (RNAcentral does not include circRNAs and their corresponding information). In summary, six miRNA inputs can be accepted in RNAenrich, including RNAcentral ID, miRBase ID (mature), miRBase ID (stem-loop), Official Symbol, Gene ID, and miRNA name; five lncRNA inputs are accepted, including RNAcentral ID, Official Symbol, Gene ID, Ensembl ID, and lncRNA name; circRNA ID and circRNA name can be acceptable input format; five snoRNA inputs can be accepted, including RNAcentral ID, Official Symbol, Gene ID, Ensembl ID, and snoRNA name; RNAcentral ID and piRNA name can be input formats for mouse data; mRNA analysis allows five input formats, including Gene ID, Official Symbol, UniProt ID, Ensembl ID, and RefSeq ID. In addition, RNAenrich supports one type of RNA ID to convert to another type of ID in the ID conversion module, which can be downloaded on the web page as a text file.</p>
      <table-wrap position="float" id="btad421-T1">
        <label>Table 1.</label>
        <caption>
          <p>Summary of input formats that RNAenrich supports.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Species</th>
              <th align="center" rowspan="1" colspan="1">RNA type</th>
              <th colspan="6" rowspan="1">ID type</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="5" colspan="1">Human</td>
              <td rowspan="1" colspan="1">miRNA</td>
              <td rowspan="1" colspan="1">RNAcentral ID</td>
              <td rowspan="1" colspan="1">miRBase ID (mature)</td>
              <td rowspan="1" colspan="1">miRBase ID (stem-loop)</td>
              <td rowspan="1" colspan="1">Official symbol</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">miRNA name</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">lncRNA</td>
              <td rowspan="1" colspan="1">RNAcentral ID</td>
              <td rowspan="1" colspan="1">Official symbol</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">Ensembl ID</td>
              <td rowspan="1" colspan="1">lncRNA name</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">circRNA</td>
              <td rowspan="1" colspan="1">circRNA ID</td>
              <td rowspan="1" colspan="1">circRNA name</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">snoRNA</td>
              <td rowspan="1" colspan="1">RNAcentral ID</td>
              <td rowspan="1" colspan="1">Official symbol</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">Ensembl ID</td>
              <td rowspan="1" colspan="1">snoRNA name</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">mRNA</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">Gene name</td>
              <td rowspan="1" colspan="1">Uniprot ID</td>
              <td rowspan="1" colspan="1">Ensembl ID</td>
              <td rowspan="1" colspan="1">RefSeq ID</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="6" colspan="1">Mouse</td>
              <td rowspan="1" colspan="1">miRNA</td>
              <td rowspan="1" colspan="1">RNAcentral ID</td>
              <td rowspan="1" colspan="1">miRBase ID (mature)</td>
              <td rowspan="1" colspan="1">miRBase ID (stem-loop)</td>
              <td rowspan="1" colspan="1">Official symbol</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">miRNA name</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">lncRNA</td>
              <td rowspan="1" colspan="1">RNAcentral ID</td>
              <td rowspan="1" colspan="1">Official symbol</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">Ensembl ID</td>
              <td rowspan="1" colspan="1">lncRNA name</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">circRNA</td>
              <td rowspan="1" colspan="1">circRNA ID</td>
              <td rowspan="1" colspan="1">circRNA name</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">snoRNA</td>
              <td rowspan="1" colspan="1">RNAcentral ID</td>
              <td rowspan="1" colspan="1">Official symbol</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">Ensembl ID</td>
              <td rowspan="1" colspan="1">snoRNA name</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">piRNA</td>
              <td rowspan="1" colspan="1">RNAcentral ID</td>
              <td rowspan="1" colspan="1">piRNA name</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">mRNA</td>
              <td rowspan="1" colspan="1">Gene ID</td>
              <td rowspan="1" colspan="1">Official symbol</td>
              <td rowspan="1" colspan="1">Uniprot ID</td>
              <td rowspan="1" colspan="1">Ensembl ID</td>
              <td rowspan="1" colspan="1">RefSeq ID</td>
              <td rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <sec>
      <title>3.1 The realization of the enrichment in RNAenrich</title>
      <p>Studies in ncRNAs are rapidly increasing. Uncovering the biological meaning of regulatory RNA molecules in living organisms is an important trend in the field of ncRNA research (<xref rid="btad421-B17" ref-type="bibr">Covarrubias <italic toggle="yes">et al.</italic> 2017</xref>, <xref rid="btad421-B93" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B28" ref-type="bibr">Gregory 2019</xref>, <xref rid="btad421-B63" ref-type="bibr">Slack and Chinnaiyan 2019</xref>). Enrichment analysis is a well-used strategy to apply to explore molecular biological mechanisms (<xref rid="btad421-B20" ref-type="bibr">Delorey <italic toggle="yes">et al.</italic> 2021</xref>). A few emerging enrichment web servers focus on functional annotation and enrichment of ncRNAs (<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B5" ref-type="bibr">Cardenas <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>, <xref rid="btad421-B8" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021a</xref>); however, these servers have shown a series of limitations. First, the RNA types that these servers can analyze are not diverse, only covering miRNA (<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>) or lncRNA (<xref rid="btad421-B8" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021a</xref>). Few tools can carry out enrichment analysis for other types of ncRNAs that also play crucial roles in living organisms, such as circRNA, piRNA, and snoRNA. Second, some existing tools (<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>) conduct the enrichment analysis by directly matching each ncRNA with a term (pathway or disease) according to the literature, which may miss some key information, others (<xref rid="btad421-B5" ref-type="bibr">Cardenas <italic toggle="yes">et al.</italic> 2020</xref>) employ predicted data in built-in databases, which lead to low confidence in the enrichment results. Therefore, both types of mentioned tools cannot enable to conduct a comprehensive and accurate enrichment analysis for a list of ncRNAs.</p>
      <p>In this study, many improvements have been made to overcome these limitations, including coverage of the most diverse types of ncRNA, enhanced enrichment accuracy, and introducing functional information about RNA–RNA interactions. Now, the web server can conduct a comprehensive analysis for any ncRNA set (<xref rid="btad421-F1" ref-type="fig">Fig. 1</xref>). First, RNAenrich allows users to upload an RNA list, which can be a filtered RNA list from RNA sequencing or microarray, an interacting RNA list that is predicted by a computational approach, and so on. RNA types can be miRNA, lncRNA, circRNA, snoRNA, piRNA, or mRNA/gene, and the input format can be RNAcentral ID, Gene ID, Accession ID, Official Symbol, Ensembl ID, RNA name, miRbase ID (Mature miRNA), miRbase ID (Stem-loop miRNA), UniProt ID, or RefSeq ID (<xref rid="btad421-T1" ref-type="table">Table 1</xref>). Second, the input RNAs will be matched to their target mRNA or protein using the built-in database from 14 independent databases [miRTarBase (<xref rid="btad421-B34" ref-type="bibr">Huang <italic toggle="yes">et al.</italic> 2022</xref>), miRecords (<xref rid="btad421-B86" ref-type="bibr">Xiao <italic toggle="yes">et al.</italic> 2009</xref>), miRSponge (<xref rid="btad421-B77" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2015</xref>), OncomiRDB (<xref rid="btad421-B7" ref-type="bibr">ling Chen <italic toggle="yes">et al.</italic> 2014</xref>), Gene Ontology (<xref rid="btad421-B37" ref-type="bibr">Huntley <italic toggle="yes">et al.</italic> 2016</xref>, <xref rid="btad421-B24" ref-type="bibr">Gene Ontology Consortium 2021</xref>), IntAct (<xref rid="btad421-B19" ref-type="bibr">Del Toro <italic toggle="yes">et al.</italic> 2022</xref>), StarBase (<xref rid="btad421-B22" ref-type="bibr">Fu <italic toggle="yes">et al.</italic> 2022</xref>), TarBase (<xref rid="btad421-B41" ref-type="bibr">Karagkouni <italic toggle="yes">et al.</italic> 2018</xref>), LncTarD (<xref rid="btad421-B97" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic> 2020</xref>), LncACTdb (<xref rid="btad421-B76" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2022b</xref>), LncRNA2Target (<xref rid="btad421-B16" ref-type="bibr">Cheng <italic toggle="yes">et al.</italic> 2019</xref>), circRNADisease (<xref rid="btad421-B98" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic> 2018</xref>), SnoDB (<xref rid="btad421-B4" ref-type="bibr">Bouchard-Bourelle <italic toggle="yes">et al.</italic> 2020</xref>), and piRBase (<xref rid="btad421-B75" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2022a</xref>)], which have experimentally validated ncRNA–target interactions of 1.87 million pairs covering all regulatory RNA types. Third, the mapped mRNAs will be enriched in five ways based on information from nine databases, namely, (i) signaling pathway, (ii) metabolic pathway, (iii) Gene Ontology, (iv) disease, and (v) therapeutic target; all of enrichment categories have attracted increasing attention in the field of RNA (<xref rid="btad421-B55" ref-type="bibr">Matsui and Corey 2017</xref>, <xref rid="btad421-B1" ref-type="bibr">Anastasiadou <italic toggle="yes">et al.</italic> 2018</xref>, <xref rid="btad421-B9" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2018a</xref>, <xref rid="btad421-B94" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2019a</xref>, <xref rid="btad421-B100" ref-type="bibr">Zhu <italic toggle="yes">et al.</italic> 2019</xref>). Then, the enriched results will be presented as downloadable tables and visualized pictures, including bar plots, bubble plots, pathway correlation plots, and protein–protein interaction (PPI) networks. Specifically, the added PPI network will describe the regulatory molecular mechanism at the protein level in which the ncRNAs are involved. The network reveals PPIs that ncRNAs regulate via multiple signaling pathways. Finally, if users want to explore the RNA network that a query ncRNA regulates, RNA–RNA interaction module can provide an RNA–RNA regulatory network profile to show further detailed mechanisms.</p>
      <fig position="float" id="btad421-F1">
        <label>Figure 1.</label>
        <caption>
          <p>The workflow of RNAenrich. First, the users can input an RNA list; in this step, six types of RNA are optional. Then, the input RNA will be analyzed by built-in databases and a new enrichment strategy, matching a ncRNA with functional mRNA and then to a term. As a result, the tool will generate an enrichment analysis and an RNA–RNA interaction analysis, in which the former will be presented based on five different enrichments and the latter will profile a directional RNA–RNA regulatory network</p>
        </caption>
        <graphic xlink:href="btad421f1" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.2 The statistics of RNAenrich and current ncRNA enrichment server</title>
      <p>Some existing tools employ a direct strategy, mapping an ncRNA to a term (a disease, a pathway, and so on) to generate an enrichment analysis (<xref rid="btad421-T2" ref-type="table">Table 2</xref>). Mechanically, as all ncRNAs execute their function depending on their associated coding RNAs or proteins, such a strategy may lead to the missing of target-associated functional information. Therefore, RNAenrich uses experiment-supported ncRNA–target interactions as built-in data to map their targets of query ncRNA list and capture the function of these targets by databases, such as KEGG and Reactome, which will generate a more comprehensive enrichment analysis relying on associated targets. Furthermore, these existing tools, such as TAM and MEAA, focus on the enrichment analysis of a single type of ncRNA, while RNAenrich includes five types of popular ncRNAs (miRNA, lncRNA, circRNA, snoRNA, and piRNA) and has sufficient coverage of ncRNA number in humans and mice (<xref rid="btad421-T3" ref-type="table">Table 3</xref>).</p>
      <table-wrap position="float" id="btad421-T2">
        <label>Table 2.</label>
        <caption>
          <p>Main content and function of RNAenrich and other representative web servers.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Server</th>
              <th align="center" rowspan="1" colspan="1">RNA type</th>
              <th align="center" rowspan="1" colspan="1">Evidence</th>
              <th align="center" rowspan="1" colspan="1">Enriched strategy</th>
              <th align="center" rowspan="1" colspan="1">Respective features</th>
              <th align="center" rowspan="1" colspan="1">Reference</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">RNAenrich</td>
              <td rowspan="1" colspan="1">Six types</td>
              <td rowspan="1" colspan="1">Experiment-supported</td>
              <td rowspan="1" colspan="1">ncRNA-mRNA-term</td>
              <td rowspan="1" colspan="1">Pathway; metabolism; function; disease; therapeutic target; network</td>
              <td rowspan="1" colspan="1">This study</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">TAM</td>
              <td rowspan="1" colspan="1">miRNA</td>
              <td rowspan="1" colspan="1">Experiment-supported</td>
              <td rowspan="1" colspan="1">miRNA-term</td>
              <td rowspan="1" colspan="1">Function; disease; transcription factor; classification; tissue and cell</td>
              <td rowspan="1" colspan="1">(<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">miEAA</td>
              <td rowspan="1" colspan="1">miRNA</td>
              <td rowspan="1" colspan="1">Experiment-supported</td>
              <td rowspan="1" colspan="1">miRNA-term (most)</td>
              <td rowspan="1" colspan="1">Function; disease; transcription factor; classification; tissue and cell; pathway; biomarker; localization</td>
              <td rowspan="1" colspan="1">(<xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LncSEA</td>
              <td rowspan="1" colspan="1">lncRNA</td>
              <td rowspan="1" colspan="1">Experiment-supported</td>
              <td rowspan="1" colspan="1">lncRNA-term</td>
              <td rowspan="1" colspan="1">Function; disease; transcription factor; cancer; biomarker; regulation; drug</td>
              <td rowspan="1" colspan="1">(<xref rid="btad421-B8" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2021a</xref>)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap position="float" id="btad421-T3">
        <label>Table 3.</label>
        <caption>
          <p>Comparison of RNAenrich and other representative web servers in coverage of RNA types and species.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="2" colspan="1">Server</th>
              <th colspan="2" rowspan="1">miRNA<hr/></th>
              <th colspan="2" rowspan="1">lncRNA<hr/></th>
              <th colspan="2" rowspan="1">circRNA<hr/></th>
              <th colspan="2" rowspan="1">snoRNA<hr/></th>
              <th colspan="2" rowspan="1">piRNA<hr/></th>
              <th colspan="2" rowspan="1">mRNA<hr/></th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1">Human</th>
              <th rowspan="1" colspan="1">Mouse</th>
              <th rowspan="1" colspan="1">Human</th>
              <th rowspan="1" colspan="1">Mouse</th>
              <th rowspan="1" colspan="1">Human</th>
              <th rowspan="1" colspan="1">Mouse</th>
              <th rowspan="1" colspan="1">Human</th>
              <th rowspan="1" colspan="1">Mouse</th>
              <th rowspan="1" colspan="1">Human</th>
              <th rowspan="1" colspan="1">Mouse</th>
              <th rowspan="1" colspan="1">Human</th>
              <th rowspan="1" colspan="1">Mouse</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">RNAenrich</td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">TAM</td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">miEAA</td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LncSEA</td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>√</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>×</bold>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Taking advantage of these existing tools and adding popular trends to ncRNA research, the following five important aspects were simplified and summarized by RNAenrich to serve researchers (<xref rid="btad421-T2" ref-type="table">Table 2</xref>): (i) signaling pathway, to describe the protein-directed signaling conduction pathway that RNAs participate in, such as lncRNA AK023391 for the PI3K/Akt signaling pathway (<xref rid="btad421-B35" ref-type="bibr">Huang <italic toggle="yes">et al.</italic> 2017</xref>) and circIKBKB for the NF-κB pathway (<xref rid="btad421-B87" ref-type="bibr">Xu <italic toggle="yes">et al.</italic> 2021</xref>); (ii) metabolic pathway, to describe the metabolite-based pathway or reaction that RNAs regulate, such as lncRNA HISLA for aerobic glycolysis (<xref rid="btad421-B6" ref-type="bibr">Chen <italic toggle="yes">et al.</italic> 2019a</xref>) and miR-147b for the TCA cycle (<xref rid="btad421-B96" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic> 2019b</xref>); (iii) Gene Ontology, to describe the functional role of ncRNAs and their contribution to biological processes and location in the cell, such as lncRNA SLERT for transcription (<xref rid="btad421-B82" ref-type="bibr">Wu <italic toggle="yes">et al.</italic> 2021</xref>) and lncRNA LETN for nucleolar structure (<xref rid="btad421-B78" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2021c</xref>); (iv) disease, to describe involvement of ncRNA in the occurrence or development of disease or complications, such as miRNA-342-3p for hepatocellular carcinoma (<xref rid="btad421-B46" ref-type="bibr">Komoll <italic toggle="yes">et al.</italic> 2021</xref>) and LINC01123 for non-small cell lung cancer (<xref rid="btad421-B33" ref-type="bibr">Hua <italic toggle="yes">et al.</italic> 2019</xref>); and (v) therapeutic target, such as miRNA let-7 for immunotherapy (<xref rid="btad421-B25" ref-type="bibr">Gilles and Slack 2018</xref>) and lncRNA H19 for therapeutic target of pancreatic cancer (<xref rid="btad421-B79" ref-type="bibr">Wang <italic toggle="yes">et al.</italic> 2020</xref>). Each of these aspects has contributed to a bulk of publications, to reveal the physiological and pathophysiological mechanism, by exploration of ncRNA associations.</p>
    </sec>
    <sec>
      <title>3.3 Comparing RNAenrich with existing tools based on COVID-19 data</title>
      <p>To date, two online tools have already been developed for conducting an enrichment analysis for miRNAs, including TAM (<xref rid="btad421-B50" ref-type="bibr">Li <italic toggle="yes">et al.</italic> 2018</xref>) and miEAA (<xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>). TAM is a very popular tool for enrichment analysis of a list of miRNAs, and has been applied to the research on molecular mechanism and signaling pathway of miRNAs in diverse diseases (<xref rid="btad421-B64" ref-type="bibr">Soleimani Zakeri <italic toggle="yes">et al.</italic> 2020</xref>). Compared with the TAM, miEAA is a more comprehensive web server for miRNA enrichment and annotation, which has made many improvements, such as providing the most coverage of miRNAs, enhancing functional diversity, and integrating multiple species (<xref rid="btad421-B44" ref-type="bibr">Kern <italic toggle="yes">et al.</italic> 2020</xref>). As reported, the significance and abundance of enrichment results are key indicators of enrichment analysis (<xref rid="btad421-B88" ref-type="bibr">Yang <italic toggle="yes">et al.</italic> 2021</xref>). In other words, the more significant and abundant results a server can enrich, the more valuable information it can provide, facilitating further discovery and analysis of biological molecular mechanisms for ncRNAs (<xref rid="btad421-B88" ref-type="bibr">Yang <italic toggle="yes">et al.</italic> 2021</xref>). Therefore, in this study, we chose miEAA to compare with RNAenrich in term of the significance and abundance of enrichment results.</p>
      <p>We use a miRNA list from Khan’s study (<xref rid="btad421-B45" ref-type="bibr">Khan <italic toggle="yes">et al.</italic> 2020</xref>) as the test data, in which 106 human miRNAs are predicted to interact with SARS-CoV-2 genomic RNA. This study concluded that these miRNAs could regulate immune-signaling pathways and viral infection processes. In other words, the enrichment report of these miRNAs should be related to immune-signaling pathways, inflammation-related pathways, and virus-related diseases. Therefore, we analyzed the test list with RNAenrich and miEAA and compared the enrichment results. For the involved-signaling pathway, we summarized the pathways directly related to COVID-19. According to the authoritative studies by <xref rid="btad421-B81" ref-type="bibr">Wiersinga <italic toggle="yes">et al.</italic> (2020)</xref> and <xref rid="btad421-B3" ref-type="bibr">Blanco-Melo <italic toggle="yes">et al.</italic> (2020)</xref>, COVID-19 presents as a viral infection and replication in the early stage, and as excessive inflammatory responses and immunological stress (typical as interleukin-induced pathways) in the late stage of infection. Therefore, we filtered virus infection-, interleukin-, and immune system-related pathways in the enrichment results from both tools.</p>
      <p>Interestingly, a series of COVID-19 related pathways were significantly enriched by RNAenrich (shown in <xref rid="btad421-F2" ref-type="fig">Fig. 2</xref> and <xref rid="btad421-T4" ref-type="table">Table 4</xref>), e.g. human interleukin-4 and interleukin-13 signaling (<italic toggle="yes">P</italic> = 5.74E-14) (<italic toggle="yes">P</italic> refers to <italic toggle="yes">P</italic>.adjust), interleukin-6 signaling (<italic toggle="yes">P</italic> = 8.64E-04), and so on (shown in <xref rid="btad421-T4" ref-type="table">Table 4</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S1</xref> and <xref rid="sup1" ref-type="supplementary-material">S2</xref>). However, miEAA enrichment identified some unrelated pathways (shown in <xref rid="btad421-F2" ref-type="fig">Fig. 2</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S3</xref> and <xref rid="sup1" ref-type="supplementary-material">S4</xref>). For disease enrichment, RNAenrich captured some SARS-CoV-2-related or similar diseases (shown in <xref rid="btad421-T4" ref-type="table">Table 4</xref>), including COVID-19 (<italic toggle="yes">P</italic> = 3.49E-02), and lupus erythematosus (a type of immune system disease) (<italic toggle="yes">P</italic> = 8.28E-03); however, miEAA failed to significant diseases (shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S5</xref>), with some non-significant related terms. As shown in <xref rid="btad421-T4" ref-type="table">Table 4</xref>, a series of COVID-19-related diseases and signaling pathways were significantly enriched in RNAenrich but not in miEAA (shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S6</xref>). Overall, RNAenrich has illustrated its enhanced performance in enriching the COVID-19-related miRNA list compared with miEAA.</p>
      <fig position="float" id="btad421-F2">
        <label>Figure 2.</label>
        <caption>
          <p>Pathway enrichment results (top 10) of RNAenrich (left) and miEAA (right) for a COVID-19-related miRNA list as input. Pathway enrichment patterns included KEGG and Reactome by RNAenrich and KEGG and miRWalk by miEAA</p>
        </caption>
        <graphic xlink:href="btad421f2" position="float"/>
      </fig>
      <table-wrap position="float" id="btad421-T4">
        <label>Table 4.</label>
        <caption>
          <p>SARS-CoV-2-related pathways and diseases based on enrichment results from RNAenrich with a significant difference (<italic toggle="yes">P</italic>.adjust &lt; 0.05).</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="center" span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Description</th>
              <th rowspan="1" colspan="1">Rate</th>
              <th rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</th>
              <th rowspan="1" colspan="1"><italic toggle="yes">P</italic>.adjust</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Human T-cell leukemia virus 1 infection</td>
              <td rowspan="1" colspan="1">41/222</td>
              <td rowspan="1" colspan="1">3.07E−24</td>
              <td rowspan="1" colspan="1">2.53E−22</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Human cytomegalovirus infection</td>
              <td rowspan="1" colspan="1">39/225</td>
              <td rowspan="1" colspan="1">5.20E−22</td>
              <td rowspan="1" colspan="1">2.14E−20</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Hepatitis B</td>
              <td rowspan="1" colspan="1">32/162</td>
              <td rowspan="1" colspan="1">6.23E−20</td>
              <td rowspan="1" colspan="1">1.40E−18</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Human papillomavirus infection</td>
              <td rowspan="1" colspan="1">42/331</td>
              <td rowspan="1" colspan="1">2.33E−18</td>
              <td rowspan="1" colspan="1">3.39E−17</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Epstein–Barr virus infection</td>
              <td rowspan="1" colspan="1">32/202</td>
              <td rowspan="1" colspan="1">6.02E−17</td>
              <td rowspan="1" colspan="1">6.76E−16</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Kaposi sarcoma-associated herpesvirus infection</td>
              <td rowspan="1" colspan="1">30/194</td>
              <td rowspan="1" colspan="1">1.23E−15</td>
              <td rowspan="1" colspan="1">1.21E−14</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Hepatitis C</td>
              <td rowspan="1" colspan="1">27/157</td>
              <td rowspan="1" colspan="1">2.40E−15</td>
              <td rowspan="1" colspan="1">2.20E−14</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-4 and interleukin-13 signaling</td>
              <td rowspan="1" colspan="1">23/108</td>
              <td rowspan="1" colspan="1">1.91E−16</td>
              <td rowspan="1" colspan="1">5.74E−14</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Signaling by interleukins</td>
              <td rowspan="1" colspan="1">41/462</td>
              <td rowspan="1" colspan="1">3.83E−14</td>
              <td rowspan="1" colspan="1">3.68E−12</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Human immunodeficiency virus 1 infection</td>
              <td rowspan="1" colspan="1">20/212</td>
              <td rowspan="1" colspan="1">5.11E−07</td>
              <td rowspan="1" colspan="1">1.58E−06</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-6 signaling</td>
              <td rowspan="1" colspan="1">4/11</td>
              <td rowspan="1" colspan="1">7.61E−05</td>
              <td rowspan="1" colspan="1">8.64E−04</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-10 signaling</td>
              <td rowspan="1" colspan="1">7/47</td>
              <td rowspan="1" colspan="1">8.39E−05</td>
              <td rowspan="1" colspan="1">9.41E−04</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-3, interleukin-5, and GM-CSF signaling</td>
              <td rowspan="1" colspan="1">7/48</td>
              <td rowspan="1" colspan="1">9.63E−05</td>
              <td rowspan="1" colspan="1">1.04E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-6 family signaling</td>
              <td rowspan="1" colspan="1">5/24</td>
              <td rowspan="1" colspan="1">1.75E−04</td>
              <td rowspan="1" colspan="1">1.63E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-15 signaling</td>
              <td rowspan="1" colspan="1">4/14</td>
              <td rowspan="1" colspan="1">2.19E−04</td>
              <td rowspan="1" colspan="1">1.95E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Coronavirus disease—COVID-19</td>
              <td rowspan="1" colspan="1">15/232</td>
              <td rowspan="1" colspan="1">9.80E−04</td>
              <td rowspan="1" colspan="1">2.03E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin receptor SHC signaling</td>
              <td rowspan="1" colspan="1">5/27</td>
              <td rowspan="1" colspan="1">3.14E−04</td>
              <td rowspan="1" colspan="1">2.60E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-2 family signaling</td>
              <td rowspan="1" colspan="1">6/44</td>
              <td rowspan="1" colspan="1">4.47E−04</td>
              <td rowspan="1" colspan="1">3.53E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interleukin-7 signaling</td>
              <td rowspan="1" colspan="1">5/36</td>
              <td rowspan="1" colspan="1">1.24E−03</td>
              <td rowspan="1" colspan="1">8.16E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Lupus erythematosus</td>
              <td rowspan="1" colspan="1">9/45</td>
              <td rowspan="1" colspan="1">8.57E−04</td>
              <td rowspan="1" colspan="1">8.28E−03</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Cutaneous lupus erythematosus</td>
              <td rowspan="1" colspan="1">4/11</td>
              <td rowspan="1" colspan="1">2.66E−03</td>
              <td rowspan="1" colspan="1">1.93E−02</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">COVID-19</td>
              <td rowspan="1" colspan="1">10/70</td>
              <td rowspan="1" colspan="1">6.26E−03</td>
              <td rowspan="1" colspan="1">3.49E−02</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec>
      <title>3.4 Visualization of enrichment results in RNAenrich</title>
      <p>Currently, two functions can be carried out by RNAenrich for an ncRNA list, RNA functional enrichment and RNA–RNA interaction network analysis. According to the RNAenrich procedure, users first input the RNA list and choose some related options and then obtain the result page after 5–60 s (the waiting time depends on the number of selected databases). The result page first shows the following information: (i) an enrichment analysis report with term name, database, link ID, <italic toggle="yes">P</italic>-value, <italic toggle="yes">P</italic>.adjust, and so on, which is presented as a table and can be downloaded as CSV file; (ii) visualized plots of the enrichment results (bar plot, bubble plot, and correlation plot for selectable one and more databases) shown in <xref rid="btad421-F3" ref-type="fig">Fig. 3A–C</xref>; and (iii) a PPI network plot (shown in <xref rid="btad421-F3" ref-type="fig">Fig. 3D</xref>) to describe which PPI pairs are regulated by these ncRNAs, and these nodes with more neighbors may be key proteins that ncRNA can regulate.</p>
      <fig position="float" id="btad421-F3">
        <label>Figure 3.</label>
        <caption>
          <p>Visualization of the enrichment results by RNAenrich. Bar (A) and bubble (B) plots of enrichment results in five databases. (C) The correlation plot of enrichment results in a single database. (D) The PPI network of proteins that ncRNAs regulate is shown</p>
        </caption>
        <graphic xlink:href="btad421f3" position="float"/>
      </fig>
      <p>As the regulation among different RNAs is of great concern, e.g. miRNA–mRNA (<xref rid="btad421-B91" ref-type="bibr">Yoo <italic toggle="yes">et al.</italic> 2021b</xref>), lncRNA–miRNA–mRNA (<xref rid="btad421-B80" ref-type="bibr">Wasson <italic toggle="yes">et al.</italic> 2021</xref>), and circRNA–miRNA–mRNA (<xref rid="btad421-B57" ref-type="bibr">Neumann <italic toggle="yes">et al.</italic> 2018</xref>), our server also provides RNA–RNA interaction information in a downloadable table and picture to describe the regulatory network that a ncRNA is involved in. As shown in <xref rid="btad421-F4" ref-type="fig">Fig. 4A</xref>, the miRNA regulatory network is shown in this way because its regulatory mode is simple. For lncRNAs, the mechanism of action is more diverse, such as binding to DNA promoters, miRNAs, mRNAs, and proteins, therefore, the regulatory network of lncRNA is complicated and crosslinked (shown in <xref rid="btad421-F4" ref-type="fig">Fig. 4B</xref>), which may provide more regulatory information to uncover molecular mechanisms in diseases for users.</p>
      <fig position="float" id="btad421-F4">
        <label>Figure 4.</label>
        <caption>
          <p>Visualization of the RNA–RNA interaction network. The regulatory networks that miRNAs (A) and lncRNAs (B) direct. (<bold>A</bold>) The miRNA-central network consists of a series of miRNA–mRNA regulations, and (<bold>B</bold>) the lncRNA-central network consists of diverse regulations, such as lncRNA–miRNA, miRNA–mRNA, lncRNA–mRNA, and lncRNA–protein.</p>
        </caption>
        <graphic xlink:href="btad421f4" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec>
    <title>4 Conclusions</title>
    <p>In this study, an online tool, RNAenrich, was developed to enable comprehensive enrichment analysis of ncRNAs. This tool is unique in that (i) it can be used for enrichment analysis for various RNA types, such as circRNAs, snoRNAs, piRNAs, miRNAs, lncRNAs, and mRNAs; (ii) the analysis can be extended by introducing millions of experimentally validated RNA–target interactions as a built-in database; and (iii) the results provide a comprehensive interacting network among various ncRNAs and targets to facilitate the mechanistic study of ncRNA function. Interest in the exploration of ncRNAs is gradually extending and transforming from interest in miRNAs and lncRNAs into interest in newly identified ncRNAs, such as circRNAs, piRNAs, and snoRNAs. RNAenrich now enables enrichment analysis of all RNA types, which will be beneficial for researchers from different ncRNA fields. Studies on ncRNAs are ongoing and expanding, and RNAenrich will also be improving to better serve the field of ncRNA research.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btad421_Supplementary_Data</label>
      <media xlink:href="btad421_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors would like to thank RNAenrich users for providing feature requests and identifying bugs.</p>
  </ack>
  <sec>
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Conflict of interest</title>
    <p>None declared.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was supported by Natural Science Foundation of Zhejiang Province [LR21H300001]; National Natural Science Foundation of China [22220102001, U1909208]; Leading Talent of the “Ten Thousand Plan”—National High-Level Talents Special Support Plan of China; Fundamental Research Fund for Central Universities [2018QNA7023]; “Double Top-Class” University Project [181201*194232101]; and Key R&amp;D Program of Zhejiang Province [2020C03010]. This work was also supported by Westlake Laboratory (Westlake Laboratory of Life Sciences and Biomedicine); Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare; Alibaba Cloud; and Information Technology Center of Zhejiang University.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>The data underlying this article are available in the article and in its online <xref rid="sup1" ref-type="supplementary-material">supplementary material</xref>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btad421-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anastasiadou</surname><given-names>E</given-names></string-name>, <string-name><surname>Jacob</surname><given-names>LS</given-names></string-name>, <string-name><surname>Slack</surname><given-names>FJ.</given-names></string-name></person-group>  <article-title>Non-coding RNA networks in cancer</article-title>. <source>Nat Rev Cancer</source>  <year>2018</year>;<volume>18</volume>:<fpage>5</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">29170536</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beermann</surname><given-names>J</given-names></string-name>, <string-name><surname>Piccoli</surname><given-names>M-T</given-names></string-name>, <string-name><surname>Viereck</surname><given-names>J</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches</article-title>. <source>Physiol Rev</source>  <year>2016</year>;<volume>96</volume>:<fpage>1297</fpage>–<lpage>325</lpage>.<pub-id pub-id-type="pmid">27535639</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blanco-Melo</surname><given-names>D</given-names></string-name>, <string-name><surname>Nilsson-Payant</surname><given-names>BE</given-names></string-name>, <string-name><surname>Liu</surname><given-names>W-C</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Imbalanced host response to SARS-CoV-2 drives development of COVID-19</article-title>. <source>Cell</source>  <year>2020</year>;<volume>181</volume>:<fpage>1036</fpage>–<lpage>45.e9</lpage>.<pub-id pub-id-type="pmid">32416070</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bouchard-Bourelle</surname><given-names>P</given-names></string-name>, <string-name><surname>Desjardins-Henri</surname><given-names>C</given-names></string-name>, <string-name><surname>Mathurin-St-Pierre</surname><given-names>D</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>snoDB: an interactive database of human snoRNA sequences, abundance and interactions</article-title>. <source>Nucleic Acids Res</source>  <year>2020</year>;<volume>48</volume>:<fpage>D220</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">31598696</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cardenas</surname><given-names>J</given-names></string-name>, <string-name><surname>Balaji</surname><given-names>U</given-names></string-name>, <string-name><surname>Gu</surname><given-names>J.</given-names></string-name></person-group>  <article-title>Cerina: systematic circRNA functional annotation based on integrative analysis of ceRNA interactions</article-title>. <source>Sci Rep</source>  <year>2020</year>;<volume>10</volume>:<fpage>22165</fpage>.<pub-id pub-id-type="pmid">33335165</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>F</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name><surname>Yang</surname><given-names>L</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Extracellular vesicle-packaged HIF-1alpha-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells</article-title>. <source>Nat Cell Biol</source>  <year>2019a</year>;<volume>21</volume>:<fpage>498</fpage>–<lpage>510</lpage>.<pub-id pub-id-type="pmid">30936474</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>HL</given-names></string-name>, <string-name><surname>Yang</surname><given-names>B</given-names></string-name>, <string-name><surname>Wang</surname><given-names>SJ</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Towards an optimal support vector machine classifier using a parallel particle swarm optimization strategy</article-title>. <source>Appl Math Comput</source>  <year>2014</year>;<volume>239</volume>:<fpage>180</fpage>–<lpage>97</lpage>.</mixed-citation>
    </ref>
    <ref id="btad421-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LncSEA: a platform for long non-coding RNA related sets and enrichment analysis</article-title>. <source>Nucleic Acids Res</source>  <year>2021a</year>;<volume>49</volume>:<fpage>D969</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">33045741</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Q</given-names></string-name>, <string-name><surname>Cai</surname><given-names>J</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Long noncoding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT/beta-catenin pathway by scaffolding EZH2</article-title>. <source>Clin Cancer Res</source>  <year>2018a</year>;<volume>24</volume>:<fpage>684</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">29138341</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name><surname>Yan</surname><given-names>CC</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Long non-coding RNAs and complex diseases: from experimental results to computational models</article-title>. <source>Brief Bioinform</source>  <year>2017</year>;<volume>18</volume>:<fpage>558</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">27345524</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name><surname>Guan</surname><given-names>NN</given-names></string-name>, <string-name><surname>Sun</surname><given-names>YZ</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>MicroRNA-small molecule association identification: from experimental results to computational models</article-title>. <source>Brief Bioinform</source>  <year>2018b</year>;<volume>21</volume>:<fpage>47</fpage>–<lpage>61</lpage>.</mixed-citation>
    </ref>
    <ref id="btad421-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name><surname>Xie</surname><given-names>D</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Q</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>MicroRNAs and complex diseases: from experimental results to computational models</article-title>. <source>Brief Bioinform</source>  <year>2019b</year>;<volume>20</volume>:<fpage>515</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">29045685</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>P</given-names></string-name>, <string-name><surname>Li</surname><given-names>C</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>iLearnPlus: a comprehensive and automated machine-learning platform for nucleic acid and protein sequence analysis, prediction and visualization</article-title>. <source>Nucleic Acids Res</source>  <year>2021b</year>;<volume>49</volume>:<fpage>e60</fpage>.<pub-id pub-id-type="pmid">33660783</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>P</given-names></string-name>, <string-name><surname>Li</surname><given-names>F</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>iFeature: a python package and web server for features extraction and selection from protein and peptide sequences</article-title>. <source>Bioinformatics</source>  <year>2018c</year>;<volume>34</volume>:<fpage>2499</fpage>–<lpage>502</lpage>.<pub-id pub-id-type="pmid">29528364</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>P</given-names></string-name>, <string-name><surname>Li</surname><given-names>F</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>iLearn: an integrated platform and meta-learner for feature engineering, machine-learning analysis and modeling of DNA, RNA and protein sequence data</article-title>. <source>Brief Bioinform</source>  <year>2020</year>;<volume>21</volume>:<fpage>1047</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">31067315</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>L</given-names></string-name>, <string-name><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name><surname>Tian</surname><given-names>R</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse</article-title>. <source>Nucleic Acids Res</source>  <year>2019</year>;<volume>47</volume>:<fpage>D140</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">30380072</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Covarrubias</surname><given-names>S</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>EK</given-names></string-name>, <string-name><surname>Shapleigh</surname><given-names>B</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>CRISPR/cas-based screening of long non-coding RNAs (lncRNAs) in macrophages with an NF-kappaB reporter</article-title>. <source>J Biol Chem</source>  <year>2017</year>;<volume>292</volume>:<fpage>20911</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">29051223</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cruickshank</surname><given-names>BM</given-names></string-name>, <string-name><surname>Wasson</surname><given-names>M-CD</given-names></string-name>, <string-name><surname>Brown</surname><given-names>JM</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LncRNA PART1 promotes proliferation and migration, is associated with cancer stem cells, and alters the miRNA landscape in triple-negative breast cancer</article-title>. <source>Cancers</source>  <year>2021</year>;<volume>13</volume>:<fpage>2644</fpage>.<pub-id pub-id-type="pmid">34072264</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Del Toro</surname><given-names>N</given-names></string-name>, <string-name><surname>Shrivastava</surname><given-names>A</given-names></string-name>, <string-name><surname>Ragueneau</surname><given-names>E</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>The IntAct database: efficient access to fine-grained molecular interaction data</article-title>. <source>Nucleic Acids Res</source>  <year>2022</year>;<volume>50</volume>:<fpage>D648</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">34761267</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delorey</surname><given-names>TM</given-names></string-name>, <string-name><surname>Ziegler</surname><given-names>CGK</given-names></string-name>, <string-name><surname>Heimberg</surname><given-names>G</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets</article-title>. <source>Nature</source>  <year>2021</year>;<volume>595</volume>:<fpage>107</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">33915569</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elling</surname><given-names>R</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>EK</given-names></string-name>, <string-name><surname>Shapleigh</surname><given-names>B</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Genetic models reveal cis and trans immune-regulatory activities for lincRNA-Cox2</article-title>. <source>Cell Rep</source>  <year>2018</year>;<volume>25</volume>:<fpage>1511</fpage>–<lpage>24.e6</lpage>.<pub-id pub-id-type="pmid">30404006</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fu</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Optimization of metabolomic data processing using NOREVA</article-title>. <source>Nat Protoc</source>  <year>2022</year>;<volume>17</volume>:<fpage>129</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">34952956</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gebert</surname><given-names>LF, R</given-names></string-name>, <string-name><surname>MacRae</surname><given-names>IJ.</given-names></string-name></person-group>  <article-title>Regulation of microRNA function in animals</article-title>. <source>Nat Rev Mol Cell Biol</source>  <year>2019</year>;<volume>20</volume>:<fpage>21</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">30108335</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B24">
      <mixed-citation publication-type="journal"><collab>Gene Ontology Consortium</collab>. <article-title>The Gene Ontology resource: enriching a GOld mine</article-title>. <source>Nucleic Acids Res</source>  <year>2021</year>;<volume>49</volume>:<fpage>D325</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">33290552</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gilles</surname><given-names>ME</given-names></string-name>, <string-name><surname>Slack</surname><given-names>FJ.</given-names></string-name></person-group>  <article-title>Let-7 microRNA as a potential therapeutic target with implications for immunotherapy</article-title>. <source>Expert Opin Ther Targets</source>  <year>2018</year>;<volume>22</volume>:<fpage>929</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">30328720</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gillespie</surname><given-names>M</given-names></string-name>, <string-name><surname>Jassal</surname><given-names>B</given-names></string-name>, <string-name><surname>Stephan</surname><given-names>R</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>The reactome pathway knowledgebase 2022</article-title>. <source>Nucleic Acids Res</source>  <year>2022</year>;<volume>50</volume>:<fpage>D687</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">34788843</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goodall</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Wickramasinghe</surname><given-names>VO.</given-names></string-name></person-group>  <article-title>RNA in cancer</article-title>. <source>Nat Rev Cancer</source>  <year>2021</year>;<volume>21</volume>:<fpage>22</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">33082563</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gregory</surname><given-names>PA.</given-names></string-name></person-group>  <article-title>The miR-200-Quaking axis functions in tumour angiogenesis</article-title>. <source>Oncogene</source>  <year>2019</year>;<volume>38</volume>:<fpage>6767</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">31406253</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsu</surname><given-names>JB-K</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>C-M</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S-D</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miRTar: an integrated system for identifying miRNA-target interactions in human</article-title>. <source>BMC Bioinformatics</source>  <year>2011</year>;<volume>12</volume>:<fpage>300</fpage>.<pub-id pub-id-type="pmid">21791068</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>J</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H</given-names></string-name>, <string-name><surname>Heidari</surname><given-names>AA</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Orthogonal learning covariance matrix for defects of grey wolf optimizer: insights, balance, diversity, and feature selection</article-title>. <source>Knowl Based Syst</source>  <year>2021</year>;<volume>213</volume>:<fpage>106684</fpage>.</mixed-citation>
    </ref>
    <ref id="btad421-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>J</given-names></string-name>, <string-name><surname>Gui</surname><given-names>W</given-names></string-name>, <string-name><surname>Heidari</surname><given-names>AA</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Dispersed foraging slime mould algorithm: continuous and binary variants for global optimization and wrapper-based feature selection</article-title>. <source>Knowl Based Syst</source>  <year>2022a</year>;<volume>237</volume>:<fpage>107761</fpage>.</mixed-citation>
    </ref>
    <ref id="btad421-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>J</given-names></string-name>, <string-name><surname>Han</surname><given-names>Z</given-names></string-name>, <string-name><surname>Heidari</surname><given-names>AA</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Detection of COVID-19 severity using blood gas analysis parameters and Harris hawks optimized extreme learning machine</article-title>. <source>Comput Biol Med</source>  <year>2022b</year>;<volume>142</volume>:<fpage>105166</fpage>.<pub-id pub-id-type="pmid">35077935</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hua</surname><given-names>Q</given-names></string-name>, <string-name><surname>Jin</surname><given-names>M</given-names></string-name>, <string-name><surname>Mi</surname><given-names>B</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis</article-title>. <source>J Hematol Oncol</source>  <year>2019</year>;<volume>12</volume>:<fpage>91</fpage>.<pub-id pub-id-type="pmid">31488218</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>H-Y</given-names></string-name>, <string-name><surname>Lin</surname><given-names>Y-C-D</given-names></string-name>, <string-name><surname>Cui</surname><given-names>S</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions</article-title>. <source>Nucleic Acids Res</source>  <year>2022</year>;<volume>50</volume>:<fpage>D222</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">34850920</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Hou</surname><given-names>L</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/akt signaling pathway</article-title>. <source>J Exp Clin Cancer Res</source>  <year>2017</year>;<volume>36</volume>:<fpage>194</fpage>.<pub-id pub-id-type="pmid">29282102</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huntley</surname><given-names>RP</given-names></string-name>, <string-name><surname>Kramarz</surname><given-names>B</given-names></string-name>, <string-name><surname>Sawford</surname><given-names>T</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Expanding the horizons of microRNA bioinformatics</article-title>. <source>RNA</source>  <year>2018</year>;<volume>24</volume>:<fpage>1005</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">29871895</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huntley</surname><given-names>RP</given-names></string-name>, <string-name><surname>Sitnikov</surname><given-names>D</given-names></string-name>, <string-name><surname>Orlic-Milacic</surname><given-names>M</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Guidelines for the functional annotation of microRNAs using the gene ontology</article-title>. <source>RNA</source>  <year>2016</year>;<volume>22</volume>:<fpage>667</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">26917558</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jewison</surname><given-names>T</given-names></string-name>, <string-name><surname>Su</surname><given-names>Y</given-names></string-name>, <string-name><surname>Disfany</surname><given-names>FM</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>SMPDB 2.0: big improvements to the small molecule pathway database</article-title>. <source>Nucleic Acids Res</source>  <year>2014</year>;<volume>42</volume>:<fpage>D478</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">24203708</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname><given-names>C</given-names></string-name>, <string-name><surname>Bi</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>PASSION: an ensemble neural network approach for identifying the binding sites of RBPs on circRNAs</article-title>. <source>Bioinformatics</source>  <year>2020</year>;<volume>36</volume>:<fpage>4276</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">32426818</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanehisa</surname><given-names>M</given-names></string-name>, <string-name><surname>Furumichi</surname><given-names>M</given-names></string-name>, <string-name><surname>Sato</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>KEGG: integrating viruses and cellular organisms</article-title>. <source>Nucleic Acids Res</source>  <year>2021</year>;<volume>49</volume>:<fpage>D545</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">33125081</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karagkouni</surname><given-names>D</given-names></string-name>, <string-name><surname>Paraskevopoulou</surname><given-names>MD</given-names></string-name>, <string-name><surname>Chatzopoulos</surname><given-names>S</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions</article-title>. <source>Nucleic Acids Res</source>  <year>2018</year>;<volume>46</volume>:<fpage>D239</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">29156006</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kehl</surname><given-names>T</given-names></string-name>, <string-name><surname>Kern</surname><given-names>F</given-names></string-name>, <string-name><surname>Backes</surname><given-names>C</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miRPathDB 2.0: a novel release of the miRNA pathway dictionary database</article-title>. <source>Nucleic Acids Res</source>  <year>2020</year>;<volume>48</volume>:<fpage>D142</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">31691816</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kern</surname><given-names>F</given-names></string-name>, <string-name><surname>Aparicio-Puerta</surname><given-names>E</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miRTargetLink 2.0-interactive miRNA target gene and target pathway networks</article-title>. <source>Nucleic Acids Res</source>  <year>2021</year>;<volume>49</volume>:<fpage>W409</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">34009375</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kern</surname><given-names>F</given-names></string-name>, <string-name><surname>Fehlmann</surname><given-names>T</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>J</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems</article-title>. <source>Nucleic Acids Res</source>  <year>2020</year>;<volume>48</volume>:<fpage>W521</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">32374865</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khan</surname><given-names>MA-A-K</given-names></string-name>, <string-name><surname>Sany</surname><given-names>MRU</given-names></string-name>, <string-name><surname>Islam</surname><given-names>MS</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19</article-title>. <source>Front Genet</source>  <year>2020</year>;<volume>11</volume>:<fpage>765</fpage>.<pub-id pub-id-type="pmid">32765592</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Komoll</surname><given-names>R-M</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Q</given-names></string-name>, <string-name><surname>Olarewaju</surname><given-names>O</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma</article-title>. <source>J Hepatol</source>  <year>2021</year>;<volume>74</volume>:<fpage>122</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">32738449</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kristensen</surname><given-names>LS</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>MS</given-names></string-name>, <string-name><surname>Stagsted</surname><given-names>LVW</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>The biogenesis, biology and characterization of circular RNAs</article-title>. <source>Nat Rev Genet</source>  <year>2019</year>;<volume>20</volume>:<fpage>675</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">31395983</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>X</given-names></string-name>, <string-name><surname>Kerr</surname><given-names>K</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Strategies to modulate MicroRNA functions for the treatment of cancer or organ injury</article-title>. <source>Pharmacol Rev</source>  <year>2020</year>;<volume>72</volume>:<fpage>639</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">32554488</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>F</given-names></string-name>, <string-name><surname>Yin</surname><given-names>J</given-names></string-name>, <string-name><surname>Lu</surname><given-names>M</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>DrugMAP: molecular atlas and pharma-information of all drugs</article-title>. <source>Nucleic Acids Res</source>  <year>2023</year>;<volume>51</volume>:<fpage>D1288</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">36243961</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>J</given-names></string-name>, <string-name><surname>Han</surname><given-names>X</given-names></string-name>, <string-name><surname>Wan</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>TAM 2.0: tool for MicroRNA set analysis</article-title>. <source>Nucleic Acids Res</source>  <year>2018</year>;<volume>46</volume>:<fpage>W180</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">29878154</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>J-H</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data</article-title>. <source>Nucleic Acids Res</source>  <year>2014</year>;<volume>42</volume>:<fpage>D92</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">24297251</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>YH</given-names></string-name>, <string-name><surname>Li</surname><given-names>XX</given-names></string-name>, <string-name><surname>Hong</surname><given-names>JJ</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Clinical trials, progression-speed differentiating features, and swiftness rule of the innovative targets of first-in-class drugs</article-title>. <source>Brief Bioinform</source>  <year>2020</year>;<volume>21</volume>:<fpage>649</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">30689717</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname><given-names>J</given-names></string-name>, <string-name><surname>Wen</surname><given-names>J</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Small nucleolar RNAs: insight into their function in cancer</article-title>. <source>Front Oncol</source>  <year>2019</year>;<volume>9</volume>:<fpage>587</fpage>.<pub-id pub-id-type="pmid">31338327</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>Q</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>DeepTorrent: a deep learning-based approach for predicting DNA N4-methylcytosine sites</article-title>. <source>Brief Bioinform</source>  <year>2021</year>;<volume>22</volume>:<fpage>bbaa124</fpage>.<pub-id pub-id-type="pmid">32608476</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsui</surname><given-names>M</given-names></string-name>, <string-name><surname>Corey</surname><given-names>DR.</given-names></string-name></person-group>  <article-title>Non-coding RNAs as drug targets</article-title>. <source>Nat Rev Drug Discov</source>  <year>2017</year>;<volume>16</volume>:<fpage>167</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">27444227</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname><given-names>SM</given-names></string-name>, <string-name><surname>Williams</surname><given-names>CC</given-names></string-name>, <string-name><surname>Akahori</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Small molecule recognition of disease-relevant RNA structures</article-title>. <source>Chem Soc Rev</source>  <year>2020</year>;<volume>49</volume>:<fpage>7167</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">32975549</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Neumann</surname><given-names>DP</given-names></string-name>, <string-name><surname>Goodall</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Gregory</surname><given-names>PA.</given-names></string-name></person-group>  <article-title>Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity</article-title>. <source>Semin Cell Dev Biol</source>  <year>2018</year>;<volume>75</volume>:<fpage>50</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">28789987</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ning</surname><given-names>L</given-names></string-name>, <string-name><surname>Cui</surname><given-names>T</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>B</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>MNDR v3.0: mammal ncRNA-disease repository with increased coverage and annotation</article-title>. <source>Nucleic Acids Res</source>  <year>2021</year>;<volume>49</volume>:<fpage>D160</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">32833025</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olgun</surname><given-names>G</given-names></string-name>, <string-name><surname>Nabi</surname><given-names>A</given-names></string-name>, <string-name><surname>Tastan</surname><given-names>O.</given-names></string-name></person-group>  <article-title>NoRCE: non-coding RNA sets cis enrichment tool</article-title>. <source>BMC Bioinformatics</source>  <year>2021</year>;<volume>22</volume>:<fpage>294</fpage>.<pub-id pub-id-type="pmid">34078267</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ozata</surname><given-names>DM</given-names></string-name>, <string-name><surname>Gainetdinov</surname><given-names>I</given-names></string-name>, <string-name><surname>Zoch</surname><given-names>A</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>PIWI-interacting RNAs: small RNAs with big functions</article-title>. <source>Nat Rev Genet</source>  <year>2019</year>;<volume>20</volume>:<fpage>89</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="pmid">30446728</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pillman</surname><given-names>KA</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>CA</given-names></string-name>, <string-name><surname>Roslan</surname><given-names>S</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein quaking</article-title>. <source>EMBO J</source>  <year>2018</year>;<volume>37</volume>:<fpage>e99016</fpage>.<pub-id pub-id-type="pmid">29871889</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B62">
      <mixed-citation publication-type="journal"><collab>RNAcentral Consortium</collab>. <article-title>RNAcentral 2021: secondary structure integration, improved sequence search and new member databases</article-title>. <source>Nucleic Acids Res</source>  <year>2021</year>;<volume>49</volume>:<fpage>D212</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">33106848</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slack</surname><given-names>FJ</given-names></string-name>, <string-name><surname>Chinnaiyan</surname><given-names>AM.</given-names></string-name></person-group>  <article-title>The role of non-coding RNAs in oncology</article-title>. <source>Cell</source>  <year>2019</year>;<volume>179</volume>:<fpage>1033</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">31730848</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soleimani Zakeri</surname><given-names>NS</given-names></string-name>, <string-name><surname>Pashazadeh</surname><given-names>S</given-names></string-name>, <string-name><surname>MotieGhader</surname><given-names>H.</given-names></string-name></person-group>  <article-title>Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach</article-title>. <source>Sci Rep</source>  <year>2020</year>;<volume>10</volume>:<fpage>12210</fpage>.<pub-id pub-id-type="pmid">32699331</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Statello</surname><given-names>L</given-names></string-name>, <string-name><surname>Guo</surname><given-names>C-J</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L-L</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Gene regulation by long non-coding RNAs and its biological functions</article-title>. <source>Nat Rev Mol Cell Biol</source>  <year>2021</year>;<volume>22</volume>:<fpage>96</fpage>–<lpage>118</lpage>.<pub-id pub-id-type="pmid">33353982</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B66">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>W</given-names></string-name>, <string-name><surname>Wan</surname><given-names>S</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Z</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Tumor origin detection with tissue-specific miRNA and DNA methylation markers</article-title>. <source>Bioinformatics</source>  <year>2018</year>;<volume>34</volume>:<fpage>398</fpage>–<lpage>406</lpage>.<pub-id pub-id-type="pmid">29028927</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Too</surname><given-names>J</given-names></string-name>, <string-name><surname>Liang</surname><given-names>G</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H.</given-names></string-name></person-group>  <article-title>Memory-based Harris hawk optimization with learning agents: a feature selection approach</article-title>. <source>Eng Comput</source>  <year>2022</year>;<volume>38</volume>:<fpage>4457</fpage>–<lpage>78</lpage>.</mixed-citation>
    </ref>
    <ref id="btad421-B68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Venkatesh</surname><given-names>J</given-names></string-name>, <string-name><surname>Wasson</surname><given-names>M-CD</given-names></string-name>, <string-name><surname>Brown</surname><given-names>JM</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack</article-title>. <source>Cancer Lett</source>  <year>2021</year>;<volume>509</volume>:<fpage>81</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">33848519</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vidovic</surname><given-names>D</given-names></string-name>, <string-name><surname>Huynh</surname><given-names>TT</given-names></string-name>, <string-name><surname>Konda</surname><given-names>P</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells</article-title>. <source>Cell Death Differ</source>  <year>2020</year>;<volume>27</volume>:<fpage>363</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">31197235</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B70">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vlachos</surname><given-names>IS</given-names></string-name>, <string-name><surname>Zagganas</surname><given-names>K</given-names></string-name>, <string-name><surname>Paraskevopoulou</surname><given-names>MD</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>DIANA-miRPath v3.0: deciphering microRNA function with experimental support</article-title>. <source>Nucleic Acids Res</source>  <year>2015</year>;<volume>43</volume>:<fpage>W460</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">25977294</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B71">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vollmers</surname><given-names>AC</given-names></string-name>, <string-name><surname>Covarrubias</surname><given-names>S</given-names></string-name>, <string-name><surname>Kuang</surname><given-names>D</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>A conserved long noncoding RNA, GAPLINC, modulates the immune response during endotoxic shock</article-title>. <source>Proc Natl Acad Sci USA</source>  <year>2021</year>;<volume>118</volume>:<fpage>e2016648118</fpage>.<pub-id pub-id-type="pmid">33568531</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B72">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>CC</given-names></string-name>, <string-name><surname>Han</surname><given-names>CD</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Q</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Circular RNAs and complex diseases: from experimental results to computational models</article-title>. <source>Brief Bioinform</source>  <year>2021a</year>;<volume>22</volume>:<fpage>bbab286</fpage>.<pub-id pub-id-type="pmid">34329377</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B73">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>CC</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name></person-group>  <article-title>Drug-pathway association prediction: from experimental results to computational models</article-title>. <source>Brief Bioinform</source>  <year>2021b</year>;<volume>22</volume>:<fpage>bbaa061</fpage>.<pub-id pub-id-type="pmid">32393976</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B74">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>D</given-names></string-name>, <string-name><surname>Gu</surname><given-names>J</given-names></string-name>, <string-name><surname>Wang</surname><given-names>T</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs</article-title>. <source>Bioinformatics</source>  <year>2014</year>;<volume>30</volume>:<fpage>2237</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">24651967</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B75">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>piRBase: integrating piRNA annotation in all aspects</article-title>. <source>Nucleic Acids Res</source>  <year>2022a</year>;<volume>50</volume>:<fpage>D265</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">34871445</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B76">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name><surname>Guo</surname><given-names>Q</given-names></string-name>, <string-name><surname>Qi</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LncACTdb 3.0: an updated database of experimentally supported ceRNA interactions and personalized networks contributing to precision medicine</article-title>. <source>Nucleic Acids Res</source>  <year>2022b</year>;<volume>50</volume>:<fpage>D183</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">34850125</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B77">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name><surname>Zhi</surname><given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs</article-title>. <source>Database (Oxford)</source>  <year>2015</year>;<volume>2015</volume>:<fpage>bav098</fpage>.<pub-id pub-id-type="pmid">26424084</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B78">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name><surname>Hu</surname><given-names>X</given-names></string-name>, <string-name><surname>Song</surname><given-names>W</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Mutual dependency between lncRNA LETN and protein NPM1 in controlling the nucleolar structure and functions sustaining cell proliferation</article-title>. <source>Cell Res</source>  <year>2021c</year>;<volume>31</volume>:<fpage>664</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">33432115</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B79">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name><surname>Li</surname><given-names>F</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics</article-title>. <source>Nucleic Acids Res</source>  <year>2020</year>;<volume>48</volume>:<fpage>D1031</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">31691823</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B80">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wasson</surname><given-names>M-CD</given-names></string-name>, <string-name><surname>Brown</surname><given-names>JM</given-names></string-name>, <string-name><surname>Venkatesh</surname><given-names>J</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Datasets exploring putative lncRNA-miRNA-mRNA axes in breast cancer cell lines</article-title>. <source>Data Brief</source>  <year>2021</year>;<volume>37</volume>:<fpage>107241</fpage>.<pub-id pub-id-type="pmid">34235238</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B81">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wiersinga</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Rhodes</surname><given-names>A</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>AC</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review</article-title>. <source>JAMA</source>  <year>2020</year>;<volume>324</volume>:<fpage>782</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">32648899</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B82">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>M</given-names></string-name>, <string-name><surname>Xu</surname><given-names>G</given-names></string-name>, <string-name><surname>Han</surname><given-names>C</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>lncRNA SLERT controls phase separation of FC/DFCs to facilitate Pol I transcription</article-title>. <source>Science</source>  <year>2021</year>;<volume>373</volume>:<fpage>547</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">34326237</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B83">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>X</given-names></string-name>, <string-name><surname>Watson</surname><given-names>M.</given-names></string-name></person-group>  <article-title>CORNA: testing gene lists for regulation by microRNAs</article-title>. <source>Bioinformatics</source>  <year>2009</year>;<volume>25</volume>:<fpage>832</fpage>–<lpage>3</lpage>.<pub-id pub-id-type="pmid">19181683</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B84">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xia</surname><given-names>J</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Yang</surname><given-names>D</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Performance optimization of support vector machine with oppositional grasshopper optimization for acute appendicitis diagnosis</article-title>. <source>Comput Biol Med</source>  <year>2022a</year>;<volume>143</volume>:<fpage>105206</fpage>.<pub-id pub-id-type="pmid">35101730</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B85">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xia</surname><given-names>J</given-names></string-name>, <string-name><surname>Yang</surname><given-names>D</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Evolving kernel extreme learning machine for medical diagnosis via a disperse foraging sine cosine algorithm</article-title>. <source>Comput Biol Med</source>  <year>2022b</year>;<volume>141</volume>:<fpage>105137</fpage>.<pub-id pub-id-type="pmid">34953358</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B86">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiao</surname><given-names>F</given-names></string-name>, <string-name><surname>Zuo</surname><given-names>Z</given-names></string-name>, <string-name><surname>Cai</surname><given-names>G</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miRecords: an integrated resource for microRNA-target interactions</article-title>. <source>Nucleic Acids Res</source>  <year>2009</year>;<volume>37</volume>:<fpage>D105</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">18996891</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B87">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name><surname>Liao</surname><given-names>X</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-kappaB/bone remodeling factors signaling</article-title>. <source>Mol Cancer</source>  <year>2021</year>;<volume>20</volume>:<fpage>98</fpage>.<pub-id pub-id-type="pmid">34325714</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B88">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Li</surname><given-names>B</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>MMEASE: online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis</article-title>. <source>J Proteomics</source>  <year>2021</year>;<volume>232</volume>:<fpage>104023</fpage>.<pub-id pub-id-type="pmid">33130111</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B89">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Li</surname><given-names>B</given-names></string-name>, <string-name><surname>Tang</surname><given-names>J</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data</article-title>. <source>Brief Bioinform</source>  <year>2020</year>;<volume>21</volume>:<fpage>1058</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">31157371</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B90">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yoo</surname><given-names>JY</given-names></string-name>, <string-name><surname>Yeh</surname><given-names>M</given-names></string-name>, <string-name><surname>Kaur</surname><given-names>B</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Targeted delivery of small noncoding RNA for glioblastoma</article-title>. <source>Cancer Lett</source>  <year>2021a</year>;<volume>500</volume>:<fpage>274</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">33176185</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B91">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yoo</surname><given-names>J-Y</given-names></string-name>, <string-name><surname>Yeh</surname><given-names>M</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y-Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>MicroRNA-138 increases chemo-sensitivity of glioblastoma through downregulation of Survivin</article-title>. <source>Biomedicines</source>  <year>2021b</year>;<volume>9</volume>:<fpage>780</fpage>.<pub-id pub-id-type="pmid">34356844</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B92">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeng</surname><given-names>X</given-names></string-name>, <string-name><surname>Lin</surname><given-names>W</given-names></string-name>, <string-name><surname>Guo</surname><given-names>M</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>A comprehensive overview and evaluation of circular RNA detection tools</article-title>. <source>PLoS Comput Biol</source>  <year>2017</year>;<volume>13</volume>:<fpage>e1005420</fpage>.<pub-id pub-id-type="pmid">28594838</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B93">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Zou</surname><given-names>S</given-names></string-name>, <string-name><surname>Deng</surname><given-names>L.</given-names></string-name></person-group>  <article-title>Gene Ontology-based function prediction of long non-coding RNAs using bi-random walk</article-title>. <source>BMC Med Genomics</source>  <year>2018</year>;<volume>11</volume>:<fpage>99</fpage>.<pub-id pub-id-type="pmid">30453964</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B94">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>WC</given-names></string-name>, <string-name><surname>Wells</surname><given-names>JM</given-names></string-name>, <string-name><surname>Chow</surname><given-names>K-H</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma</article-title>. <source>Nat Metab</source>  <year>2019a</year>;<volume>1</volume>:<fpage>460</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">31535082</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B95">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname><given-names>H</given-names></string-name>, <string-name><surname>Lian</surname><given-names>X</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>ANPELA: significantly enhanced quantification tool for cytometry-based single-cell proteomics</article-title>. <source>Adv Sci (Weinh)</source>  <year>2023</year>;<volume>10</volume>:<fpage>e2207061</fpage>.<pub-id pub-id-type="pmid">36950745</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B96">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Shi</surname><given-names>J</given-names></string-name>, <string-name><surname>Rassoulzadegan</surname><given-names>M</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Sperm RNA code programmes the metabolic health of offspring</article-title>. <source>Nat Rev Endocrinol</source>  <year>2019b</year>;<volume>15</volume>:<fpage>489</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">31235802</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B97">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>H</given-names></string-name>, <string-name><surname>Shi</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases</article-title>. <source>Nucleic Acids Res</source>  <year>2020</year>;<volume>48</volume>:<fpage>D118</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">31713618</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B98">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K</given-names></string-name>, <string-name><surname>Wu</surname><given-names>F</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>circRNA disease: a manually curated database of experimentally supported circRNA-disease associations</article-title>. <source>Cell Death Dis</source>  <year>2018</year>;<volume>9</volume>:<fpage>475</fpage>.<pub-id pub-id-type="pmid">29700306</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B99">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lian</surname><given-names>X</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents</article-title>. <source>Nucleic Acids Res</source>  <year>2022</year>;<volume>50</volume>:<fpage>D1398</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="pmid">34718717</pub-id></mixed-citation>
    </ref>
    <ref id="btad421-B100">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname><given-names>K-P</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C-L</given-names></string-name>, <string-name><surname>Ma</surname><given-names>X-L</given-names></string-name></person-group>  <etal>et al</etal>  <article-title>Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance</article-title>. <source>Mol Ther</source>  <year>2019</year>;<volume>27</volume>:<fpage>518</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">30692017</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
